SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Eagle Wealth Strategies LLC

Eagle Wealth Strategies LLC cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 25.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,043 shares of the exchange traded fund’s stock after selling 1,404 shares during the period. Eagle Wealth Strategies LLC’s holdings in SPDR S&P Biotech ETF were worth $399,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in XBI. Scarborough Advisors LLC purchased a new position in SPDR S&P Biotech ETF in the fourth quarter valued at about $32,000. ORG Partners LLC purchased a new position in SPDR S&P Biotech ETF in the second quarter valued at about $40,000. Vima LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $45,000. Resources Management Corp CT ADV increased its stake in shares of SPDR S&P Biotech ETF by 30.3% during the 2nd quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after purchasing an additional 138 shares in the last quarter. Finally, SOA Wealth Advisors LLC. increased its stake in shares of SPDR S&P Biotech ETF by 79.8% during the 1st quarter. SOA Wealth Advisors LLC. now owns 597 shares of the exchange traded fund’s stock worth $57,000 after purchasing an additional 265 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 0.7 %

Shares of XBI traded down $0.67 during mid-day trading on Wednesday, reaching $96.43. 1,129,256 shares of the company’s stock were exchanged, compared to its average volume of 9,563,567. The company has a 50-day simple moving average of $98.60 and a two-hundred day simple moving average of $94.09. SPDR S&P Biotech ETF has a 52-week low of $63.80 and a 52-week high of $103.52. The company has a market cap of $7.35 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.